Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

53.17
-1.0500-1.94%
Post-market: 53.320.1500+0.28%18:59 EDT
Volume:3.88M
Turnover:209.47M
Market Cap:2.16B
PE:- -
High:54.87
Open:54.19
Low:53.04
Close:54.22
52wk High:55.30
52wk Low:24.60
Shares:40.65M
Float Shares:40.65M
Volume Ratio:1.03
T/O Rate:9.54%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

H.C. Wainwright Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Yesterday

Twist Bioscience is Maintained at Buy by Guggenheim

Dow Jones
·
Yesterday

Tempus AI price target raised to $92 from $65 at Guggenheim

TIPRANKS
·
Yesterday

Twist Bioscience price target raised to $212 from $107 at Guggenheim

TIPRANKS
·
Yesterday

Tempus AI Says 13 Clinical Research Abstracts Win ESMO 2026 Presentation Slots

Reuters
·
Yesterday

Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026

THOMSON REUTERS
·
Yesterday

October Golden Stock Picks from Brokerages Revealed, Covering Pharmaceuticals, Information Technology, and More; WuXi AppTec and Zhongji Innolight Receive the Most Recommendations (List)

Deep News
·
Yesterday

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI), Summit Therapeutics (SMMT) and Sutro Biopharma (STRO)

TIPRANKS
·
Yesterday

Arkema Boosts Global Battery R&D With €10 Million Expansion in France

TIPRANKS
·
Yesterday

Talga Advances Japanese Offtake Talks for Swedish Graphite Anode Supply

TIPRANKS
·
Yesterday

Cathie Wood’s ARK Investment buys 467K shares of Intellia Therapeutics today

TIPRANKS
·
Yesterday

SpaceX Stock Forecast: 2 ETFs to Capture SPCX’s 56% Upside Potential as Cathie Wood Invests $1.3M

TIPRANKS
·
Sep 30

DK&D Sets 2026 Corporate Value Plan to Boost Valuation and Shareholder Returns

TIPRANKS
·
Sep 30

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Disposes of $873,885 in Common Shares

Reuters
·
Sep 30

Chorus seeks shareholder approval to modernise constitution and remove NZX non-standard status

TIPRANKS
·
Sep 30

10x Genomics Price Target Raised to $90.00/Share from $40.00 by Leerink Partners

Dow Jones
·
Sep 30

10x Genomics Begins Commercial Shipments of Atera

MT Newswires Live
·
Sep 29

10x Genomics price target raised to $90 from $40 at Leerink

TIPRANKS
·
Sep 29

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

TIPRANKS
·
Sep 29

Highway Holdings Sets October 26, 2026 Shareholder Meeting and Distributes Proxy Materials

TIPRANKS
·
Sep 29